Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin receptor antagonists: a review of promising compounds patented since 2006
Paul J. Coleman, John J. Renger
Expert Opinion on Therapeutic Patents (2010) Vol. 20, Iss. 3, pp. 307-324
Closed Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Orexin Receptors: Pharmacology and Therapeutic Opportunities
Thomas E. Scammell, Christopher J. Winrow
The Annual Review of Pharmacology and Toxicology (2011) Vol. 51, Iss. 1, pp. 243-266
Open Access | Times Cited: 350
Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia
Christopher D. Cox, Michael J. Breslin, David B. Whitman, et al.
Journal of Medicinal Chemistry (2010) Vol. 53, Iss. 14, pp. 5320-5332
Closed Access | Times Cited: 348
Orexin/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus
Robert M. Sears, Ann E. Fink, Mattis B. Wigestrand, et al.
Proceedings of the National Academy of Sciences (2013) Vol. 110, Iss. 50, pp. 20260-20265
Open Access | Times Cited: 178
G Protein–Coupled Receptor Deorphanizations
Olivier Civelli, Rainer K. Reinscheid, Yan Zhang, et al.
The Annual Review of Pharmacology and Toxicology (2011) Vol. 53, Iss. 1, pp. 127-146
Open Access | Times Cited: 175
International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and Pharmacology
Anthony L. Gotter, Andrea L. Webber, Paul J. Coleman, et al.
Pharmacological Reviews (2012) Vol. 64, Iss. 3, pp. 389-420
Closed Access | Times Cited: 154
Discovery and development of orexin receptor antagonists as therapeutics for insomnia
Christopher J. Winrow, John J. Renger
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 283-293
Open Access | Times Cited: 144
Physiology of the orexinergic/hypocretinergic system: a revisit in 2012
Jyrki P. Kukkonen
AJP Cell Physiology (2012) Vol. 304, Iss. 1, pp. C2-C32
Closed Access | Times Cited: 133
Manipulating the sleep-wake cycle and circadian rhythms to improve clinical management of major depression
Ian B. Hickie, Sharon L. Naismith, Rébecca Robillard, et al.
BMC Medicine (2013) Vol. 11, Iss. 1
Open Access | Times Cited: 130
Discovery of [(2R,5R)‐5‐{[(5‐Fluoropyridin‐2‐yl)oxy]methyl}‐2‐methylpiperidin‐1‐yl][5‐methyl‐2‐(pyrimidin‐2‐yl)phenyl]methanone (MK‐6096): A Dual Orexin Receptor Antagonist with Potent Sleep‐Promoting Properties
Paul J. Coleman, John D. Schreier, Christopher D. Cox, et al.
ChemMedChem (2012) Vol. 7, Iss. 3, pp. 415-424
Closed Access | Times Cited: 115
The orexin story and orexin receptor antagonists for the treatment of insomnia
Clemens Muehlan, Catherine Roch, Cédric Vaillant, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 6
Open Access | Times Cited: 39
Functional Magnetic Resonance Imaging Reveals Different Neural Substrates for the Effects of Orexin-1 and Orexin-2 Receptor Antagonists
Alessandro Gozzi, Giuliano Turrini, Laura Piccoli, et al.
PLoS ONE (2011) Vol. 6, Iss. 1, pp. e16406-e16406
Open Access | Times Cited: 102
Orexin receptors as therapeutic drug targets
Anthony L. Gotter, Anthony J. Roecker, Richard Hargreaves, et al.
Progress in brain research (2012), pp. 163-188
Closed Access | Times Cited: 95
Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis
Mathieu Rappas, A. Ali, K.A. Bennett, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 4, pp. 1528-1543
Open Access | Times Cited: 65
Enantioselective Synthesis of a Dual Orexin Receptor Antagonist
Ian Mangion, Benjamin D. Sherry, Jingjun Yin, et al.
Organic Letters (2012) Vol. 14, Iss. 13, pp. 3458-3461
Closed Access | Times Cited: 70
Discovery of 5′′‐Chloro‐N‐[(5,6‐dimethoxypyridin‐2‐yl)methyl]‐2,2′:5′,3′′‐terpyridine‐3′‐carboxamide (MK‐1064): A Selective Orexin 2 Receptor Antagonist (2‐SORA) for the Treatment of Insomnia
Anthony J. Roecker, Swati P. Mercer, John D. Schreier, et al.
ChemMedChem (2013) Vol. 9, Iss. 2, pp. 311-322
Closed Access | Times Cited: 62
Rhein Reduces Fat Weight indb/dbMouse and Prevents Diet-Induced Obesity in C57Bl/6 Mouse through the Inhibition of PPARγSignaling
Yu Zhang, Shengjie Fan, Na Hu, et al.
PPAR Research (2012) Vol. 2012, pp. 1-9
Open Access | Times Cited: 59
Dual orexin receptor antagonist 12 inhibits expression of proteins in neurons and glia implicated in peripheral and central sensitization
Ryan Cady, Jennifer E. Denson, Logan Sullivan, et al.
Neuroscience (2014) Vol. 269, pp. 79-92
Closed Access | Times Cited: 53
Orexin Receptor Antagonists: A New Concept In CNS Disorders?
John Gatfield, Catherine Brisbare‐Roch, François Jenck, et al.
ChemMedChem (2010) Vol. 5, Iss. 8, pp. 1197-1214
Closed Access | Times Cited: 65
The hypocretins and the reward function: what have we learned so far?
Benjamin Boutrel, Nadia Steiner, Olivier Halfon
Frontiers in Behavioral Neuroscience (2013) Vol. 7
Open Access | Times Cited: 47
The potential role of the orexin reward system in future treatments for opioid drug abuse
Shahram Zarrabian, Esmail Riahi, Sara Karimi, et al.
Brain Research (2018) Vol. 1731, pp. 146028-146028
Closed Access | Times Cited: 39
Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis.
Mathieu Rappas, A. Ali, K.A. Bennett, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 4, pp. 1528-1543
Closed Access | Times Cited: 26
Ligand‐induced internalization of the orexin OX1 and cannabinoid CB1 receptors assessed via N‐terminal SNAP and CLIP‐tagging
Richard J. Ward, John D. Pediani, Graeme Milligan
British Journal of Pharmacology (2010) Vol. 162, Iss. 6, pp. 1439-1452
Open Access | Times Cited: 36
The orexin receptor OX1R in colon cancer: a promising therapeutic target and a new paradigm in G protein‐coupled receptor signalling through ITIMs
Marc Laburthe, Thierry Voisin
British Journal of Pharmacology (2011) Vol. 165, Iss. 6, pp. 1678-1687
Open Access | Times Cited: 33
Pharmacotherapy of insomnia
Octavian C. Ioachimescu, Ali El-Solh
Expert Opinion on Pharmacotherapy (2012) Vol. 13, Iss. 9, pp. 1243-1260
Closed Access | Times Cited: 28
Discovery of potent, selective, orally active benzoxazepine-based Orexin-2 receptor antagonists
Tatsuhiko Fujimoto, Jun Kunitomo, Yoshihide Tomata, et al.
Bioorganic & Medicinal Chemistry Letters (2011) Vol. 21, Iss. 21, pp. 6414-6416
Closed Access | Times Cited: 27
Page 1 - Next Page

Scroll to top